TTY Biopharm Company Limited (TPEX:4105)
Taiwan · Delayed Price · Currency is TWD 73.50
-0.20 (-0.27%)
Jun 18, 2026, 1:30 PM CST
TTY Biopharm Company Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 18,276 | 20,265 | 18,102 | 19,991 | 20,737 | 17,107 | |
Market Cap Growth | -2.13% | 11.95% | -9.45% | -3.60% | 21.22% | 0.29% |
Enterprise Value | 16,814 | 20,041 | 18,292 | 20,061 | 20,686 | 16,707 |
Last Close Price | 73.50 | 76.92 | 65.03 | 68.73 | 68.26 | 53.98 |
PE Ratio | 11.36 | 13.00 | 12.49 | 17.72 | 18.95 | 20.56 |
Forward PE | - | 12.86 | 12.86 | 14.81 | 17.45 | 16.54 |
PS Ratio | 2.81 | 3.14 | 3.07 | 3.63 | 4.10 | 3.77 |
PB Ratio | 2.47 | 2.52 | 2.41 | 3.07 | 3.33 | 2.97 |
P/TBV Ratio | 3.06 | 2.97 | 2.84 | 3.46 | 3.84 | 3.39 |
P/FCF Ratio | 9.59 | 12.16 | 14.79 | 19.85 | 18.12 | 14.30 |
P/OCF Ratio | 9.05 | 11.50 | 13.42 | 18.42 | 16.78 | 13.62 |
EV/Sales Ratio | 2.58 | 3.11 | 3.10 | 3.64 | 4.09 | 3.68 |
EV/EBITDA Ratio | 7.81 | 10.59 | 11.52 | 12.81 | 14.69 | 12.82 |
EV/EBIT Ratio | 8.58 | 11.76 | 13.12 | 14.62 | 16.85 | 14.65 |
EV/FCF Ratio | 8.82 | 12.02 | 14.94 | 19.92 | 18.08 | 13.97 |
Debt / Equity Ratio | 0.14 | 0.15 | 0.23 | 0.29 | 0.29 | 0.37 |
Debt / EBITDA Ratio | 0.51 | 0.64 | 1.08 | 1.19 | 1.28 | 1.65 |
Debt / FCF Ratio | 0.53 | 0.73 | 1.40 | 1.85 | 1.58 | 1.79 |
Net Debt / Equity Ratio | -0.31 | -0.22 | -0.18 | -0.15 | -0.14 | -0.08 |
Net Debt / EBITDA Ratio | -1.16 | -0.94 | -0.86 | -0.61 | -0.62 | -0.34 |
Net Debt / FCF Ratio | -1.20 | -1.06 | -1.12 | -0.95 | -0.77 | -0.38 |
Asset Turnover | 0.57 | 0.58 | 0.57 | 0.56 | 0.54 | 0.49 |
Inventory Turnover | 2.12 | 2.06 | 2.10 | 2.08 | 2.05 | 1.71 |
Quick Ratio | 1.30 | 1.72 | 1.56 | 1.62 | 1.35 | 1.23 |
Current Ratio | 1.71 | 2.28 | 2.02 | 2.08 | 1.73 | 1.56 |
Return on Equity (ROE) | 23.94% | 21.27% | 21.68% | 17.56% | 18.38% | 13.89% |
Return on Assets (ROA) | 9.83% | 9.59% | 8.40% | 8.81% | 8.12% | 7.64% |
Return on Invested Capital (ROIC) | 24.51% | 21.37% | 19.22% | 19.84% | 18.02% | 15.73% |
Return on Capital Employed (ROCE) | 22.10% | 19.60% | 17.40% | 18.80% | 18.40% | 18.30% |
Earnings Yield | 8.82% | 7.69% | 8.01% | 5.64% | 5.28% | 4.86% |
FCF Yield | 10.43% | 8.23% | 6.76% | 5.04% | 5.52% | 6.99% |
Dividend Yield | 6.12% | 5.85% | 6.46% | 5.09% | 4.98% | 5.56% |
Payout Ratio | 64.82% | 66.98% | 60.04% | 74.91% | 68.16% | 119.56% |
Buyback Yield / Dilution | -0.04% | -0.03% | -0.04% | -0.03% | 0.02% | 0.00% |
Total Shareholder Return | 6.06% | 5.82% | 6.42% | 5.06% | 5.00% | 5.56% |